Mallory Institute of Pathology is categorized under Medical Research in Boston, MA and active since 1953.
Mallory Institute of Pathology was established in 1953, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Dr Leonard S Gottlieb at the company’s single location by writing to 784 Massachusetts Avenue, Boston, Massachusetts MA 02118 or by phoning (617) 414-5309. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Mallory Institute of Pathology |
Contact Person: | Dr Leonard S Gottlieb |
Address: | 784 Massachusetts Avenue, Boston, Massachusetts 02118 |
Phone Number: | (617) 414-5309 |
Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
Founded: | 1953 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 6211110 |
Share This Business: |
Mallory Institute of Pathology was started in 1953 to provide professional Medical Research under the SIC code 8733 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Dr Leonard S Gottlieb for inquiries that concern Mallory Institute of Pathology by calling the company number (617) 414-5309, as your correspondence is most welcome. Additionally, the physical location of the single location of Mallory Institute of Pathology can be found at the coordinates 42.33558,-71.07578 as well as the street address 784 Massachusetts Avenue in Boston, Massachusetts 02118.
For its online presence, you may visit Mallory Institute of Pathology’s website at and engage with its social media outlets through on Twitter and on Facebook.